Vilya Funding & Investors
Seattle, WA
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease. The company aims to create new medicines to leverage computing to make high throughput screening obsolete and cure diseases.
vilyatx.comTotal Amount Raised: $71,000,000
Vilya Funding Rounds
Series A
$21,000,000
Series A Investors
Arch Venture PartnersAltitude Life Science VenturesMenlo VenturesLifeforce CapitalMadrona Venture GroupNVenturesSeries A
$50,000,000
Series A Investors
Arch Venture Partners
Funding info provided by Diffbot.